Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

The Bears Know Best: Stay Away From HYLN Stock

By Alex Sirois, InvestorPlace Contributor
HYLN stock is a SPAC funded EV has been which never should have received so much attention. Nothing's improved since then.

Beware: The Selloff in Jumia Technologies Stock Can Continue

By InvestorPlace Research Staff
Investors piled into JMIA stock amid a small-cap rally. After a reversal, disappointing growth and a steep valuation should deter investors.

Lordstown Motors Stock Is a Bottom of the Barrel EV Play

By InvestorPlace Research Staff
As the prior hype behind Lordstown Motors fades due to many red flags, it's clear RIDE stock isn't a great way to play the EV megatrend.

The Bull and Bear Cases for FuelCell Stock: Will It Resume Its Rise or Continue to Fall?

By Chris MacDonald, InvestorPlace Contributor
Investors looking for a green-energy growth play have looked at FCEL stock as a high-leverage way to play the green-energy revolution.

Spurred On by Analysts, Snowflake Remains Highly Overvalued

By Mark R. Hake, CFA
Snowflake stays in its own weird, overvalued world. At best, SNOW stock is worth 30 times revenue, or 16% lower than today.

Canoo Is Absolutely a Sell, Based on Persistent Troubles

By Alex Sirois, InvestorPlace Contributor
GOEV stock shouldn't be rewarded with investment capital now or anytime soon. The company is in trouble based on recent news.

Why Ocugen Stock Continues to Be a Great Short Opportunity

By Larry Ramer, InvestorPlace Contributor
No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA's preferences. OCGN stock is a short.

Don’t Chase Ocugen Stock Without Reading the Fine Print

By InvestorPlace Research Staff
OCGN stock has soared on positive vaccine data. But investors must remember that Ocugen's market and experience are sharply limited.

Quantumscape Stock Has No Business Trading, and You Have No Business Buying It

By Dana Blankenhorn, InvestorPlace Contributor
Quantumscape is a development stage company working on a solid state lithium-ion battery that would be superior to current models, assuming things work out.

Well Off Its Highs, Castor Maritime Stock Still Looks Overpriced

By Vince Martin, InvestorPlace Contributor
CTRM stock trades at a 45% premium to the cash spent on its vessels. Neither its management nor its sector seem to support that premium.

SOS Stock Is Too Expensive at $4

By Mark R. Hake, CFA
SOS stock faces further downdraft as its finances are still murky. SOS stock is still overvalued and is not worth more than $2.40, or 40% below today’s price.

3 Growth Stocks That Are Falling Out of Bed

By Tyler Craig, Tales of a Technician
Growth stocks are being battered this week. Here are the most vulnerable ones to deploy bear trades on.

4 Reddit Penny Stocks Whose Time Has Passed

By Joel Baglole, InvestorPlace Contributor
It was brief and fleeting, but the share prices of these Reddit penny stocks briefly touched new highs this year, pumped up by retail traders.

ROKU Stock Is Worth 60% Less Now That Vizio Is Public

By Mark R. Hake, CFA
Now that Vizio is public, ROKU stock could drop despite its high margins. ROKU is 7 times more expensive but worth 60% less than its current price.

Why Canoo Stock Looks Like a Dangerous Gamble

By Chris Lau, InvestorPlace Contributor
Canoo posted no revenue in Q4 and promises only inexpensive EVs sometime in the future.

Castor Maritime’s Speculative Fervor Could Be Done

By Josh Enomoto, InvestorPlace Contributor
Although CTRM stock is appealing for its cheap price and upward potential, neither the fundamentals nor technicals are supportive.

Here Are 3 Reasons Why Sundial Growers Is All Smoke and No Fire

By Stavros Georgiadis, CFA, InvestorPlace Contributor
SNDL stock had a meme-stock rally in 2021, but now it's time to reassess its fundamentals. For Sundial, things do not look good at all.

Walmart Stock Is Taking a Turn for the Worse

By Louis Navellier and the InvestorPlace Research Staff
WMT stock has long been a reliable winner for investors. But now Walmart has to figure out how to turn a profit in a post-pandemic economy.

SNDL Stock Is Need Of a Growth Story and Positive Catalysts

By Faizan Farooque, InvestorPlace Contributor
SNDL stock has fallen considerably from February highs of $4, but it lacks company-specific catalysts for long-term sustainable success.
Load More Articles